Published in J Thromb Haemost on December 01, 2003
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J Clin Invest (2006) 1.69
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency. ILAR J (2009) 1.43
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nat Commun (2013) 1.20
Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A. Mol Ther (2009) 1.19
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet (2015) 1.10
Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. J Thromb Haemost (2012) 1.09
Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood (2005) 1.00
C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. J Thromb Haemost (2013) 0.94
Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells. Haematologica (2009) 0.94
Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy. Mol Ther (2011) 0.83
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. Haematologica (2015) 0.82
VWF and FVIII: the origins of a great friendship. Blood (2009) 0.80
Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells. PLoS One (2011) 0.80
Platelet and endothelial expression of clotting factors for the treatment of hemophilia. Thromb Res (2012) 0.78
Good things come in small packages for hemophilia. J Thromb Haemost (2003) 0.77
Megakaryocyte- and megakaryocyte precursor-related gene therapies. Blood (2016) 0.75
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet (1999) 8.91
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43
PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science (1990) 5.28
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
A prokaryotic voltage-gated sodium channel. Science (2001) 4.56
A sperm ion channel required for sperm motility and male fertility. Nature (2001) 4.43
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia (2008) 3.83
Cohort changes in illegal drug use among arrestees in Manhattan: from the Heroin Injection Generation to the Blunts Generation. Subst Use Misuse (1999) 3.71
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun (1994) 3.59
Occupations of fathers of children dying from neoplasms. J Epidemiol Community Health (1981) 3.25
Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood (1990) 3.02
Platelets have more than one binding site for von Willebrand factor. J Clin Invest (1983) 2.89
The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood (1987) 2.84
Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am J Public Health (2001) 2.70
Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest (2000) 2.56
The setting for the crack era: macro forces, micro consequences (1960-1992). J Psychoactive Drugs (1993) 2.47
Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the alphaIIb gene to be strongly linked to the HPA-1b polymorphism in beta3. J Thromb Haemost (2003) 2.20
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem (1983) 2.09
Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol (1997) 2.06
Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis. Dev Biol (1983) 2.03
An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol (1974) 2.01
HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95
Removal of endotoxin from recombinant protein preparations. Clin Biochem (1997) 1.95
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. J Med Chem (2000) 1.94
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med (1983) 1.91
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A (1987) 1.87
Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med (1995) 1.87
The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis. Blood (1981) 1.86
The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes. J Biol Chem (1999) 1.84
Dihydropyrrolo[3,4-c]pyrazoles. J Med Chem (1968) 1.84
Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J (1984) 1.82
On the association of glycoprotein Ib and actin-binding protein in human platelets. J Cell Biol (1985) 1.80
The shifting importance of alcohol and marijuana as gateway substances among serious drug abusers. J Stud Alcohol (1994) 1.79
Molecular defects in interactions of platelets with the vessel wall. N Engl J Med (1984) 1.78
Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agric Food Chem (2002) 1.77
SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem (1998) 1.77
Specific roles for platelet surface glycoproteins in platelet function. Nature (1975) 1.77
Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol (2001) 1.76
Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity. J Thromb Haemost (2012) 1.76
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem (2001) 1.72
Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost (2000) 1.71
The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets. Semin Hematol (1979) 1.71
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer (2011) 1.69
Driver landmark and traffic sign identification in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.65
Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest (1988) 1.63
Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest (1981) 1.62
Low-molecular-weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol (2000) 1.62
Superior mesenteric vein thrombosis with radiologically occult cause: a retrospective study of 43 cases. AJR Am J Roentgenol (2001) 1.61
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med (1976) 1.58
Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. J Immunol (2001) 1.58
Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy (2007) 1.58
Toxic gases from fires. Science (1978) 1.54
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785). Biochem Pharmacol (1999) 1.53
Is the U.S. experiencing an incipient epidemic of hallucinogen use? Subst Use Misuse (2001) 1.51
Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron (1998) 1.51
Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene (2011) 1.50
Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo. J Thromb Haemost (2012) 1.48
Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood (2000) 1.48
Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood (1993) 1.48
von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease. J Clin Invest (1978) 1.45
Issues with the assay of factor VIII activity in plasma and factor VIII concentrates. Thromb Haemost (2000) 1.44
The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay. Am J Clin Pathol (1991) 1.43
Oxygen cost of exercise hyperpnea: implications for performance. J Appl Physiol (1985) (1992) 1.43
Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A. J Thromb Haemost (2007) 1.41
Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products. J Lab Clin Med (1990) 1.41
Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) (2007) 1.41
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer (2004) 1.40
Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest (1983) 1.40
PCB intake and the growth of waterfowl: multivariate analyses based on a reparameterized Richards sigmoid model. Growth (1986) 1.40
Driver route-following and safety errors in early Alzheimer disease. Neurology (2004) 1.40
The partial thromboplastin time. J Thromb Haemost (2014) 1.39
Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: a genotype-phenotype correlation study. Br J Dermatol (2014) 1.39
European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost (1998) 1.37
Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. J Clin Invest (1992) 1.36
Position-dependent linkages of fibronectin- integrin-cytoskeleton. Proc Natl Acad Sci U S A (2000) 1.35
Supporting the habit: income generation activities of frequent crack users compared with frequent users of other hard drugs. Drug Alcohol Depend (2001) 1.35
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol (2000) 1.35
Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35
HIV risk behaviours of current sex workers attending syringe exchange: the experiences of women in five US cities. AIDS Care (1999) 1.32
Enzymatic amplification of specific cDNA inserts from lambda gt11 libraries. Nucleic Acids Res (1988) 1.31
Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. J Biol Chem (1995) 1.30
The genomic organization of platelet glycoprotein IIIa. J Biol Chem (1990) 1.29
Type II regulatory subunits are not required for the anchoring-dependent modulation of Ca2+ channel activity by cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1997) 1.28
A recent decline in cocaine use among youthful arrestees in Manhattan, 1987 through 1993. Am J Public Health (1994) 1.28
Studying crack abusers: strategies for recruiting the right tail of an ill-defined population. J Psychoactive Drugs (1993) 1.27
Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit. J Biol Chem (1997) 1.25
Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis (2007) 1.25
Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost (2013) 1.25